Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of AT9283 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients
- Status
- COMPLETED
- Phase
- N/A
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
- Status
- COMPLETED
- Phase
- N/A
B-Receptor Signaling in Cardiomyopathy
- Status
- COMPLETED
- Phase
- N/A
VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
- Status
- UNKNOWN
- Phase
- PHASE3
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions
- Status
- COMPLETED
- Phase
- PHASE2
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE2
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM
- Status
- COMPLETED
- Phase
- PHASE1
Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)
- Status
- UNKNOWN
- Phase
- PHASE2
Prevention of Left Ventricular Dysfunction During Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
- Status
- COMPLETED
- Phase
- PHASE3